Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Merlo

Showing results (181-190 of 431) with videos related to

Pageof 44
Sort By:
European Heart Journal Supplements : Journal of the European Society of Cardiology|February 21, 2025
Critical analysis of the 2023 ESC guidelines on cardiomyopathy managementMaria Perotto, Carola Pio Loco Detto Gava, Maddalena Rossi, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 31, 2018
Early occurrence of drug intolerance as risk factor during follow-up in patients with acute coronary syndrome or coronary revascularizationStefano Albani, Enrico Fabris, Sara Doimo, et al.
Circulation. Genomic and Precision Medicine|April 1, 2026
Twenty-Five-Year Follow-Up of the MDDC1 Family: A <i>LMNA</i> Gene Variant Associated With Dilated Cardiomyopathy With Variable Skeletal Muscle InvolvementTeresa Maria Capovilla, Manuela Iseppi, Salvatore Distaso, et al.
Heart Rhythm|April 15, 2026
Incidence and predictors of major arrhythmic events following acute myocarditis complicated by ventricular arrhythmias: a systematic review and meta-analysisSoundous M'Rabet, Elisé G Kaboré, Moshe Rav-Acha, et al.
The American Journal of Cardiology|May 3, 2011
Predictors for restoration of normal left ventricular function in response to cardiac resynchronization therapy measured at time of implantationLaura Vitali Serdoz, Elisabetta Daleffe, Marco Merlo, et al.
The American Journal of Cardiology|December 20, 2011
How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with "SCD-HeFT criteria?"Massimo Zecchin, Marco Merlo, Alberto Pivetta, et al.
Heart Failure Clinics|November 15, 2021
The Arrhythmic Phenotype in CardiomyopathyMarco Merlo, Giulia Grilli, Chiara Cappelletto, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|April 16, 2024
Management of hypertrophic cardiomyopathyYuhui Zhang, Marianna Adamo, Changhong Zou, et al.
Open Heart|August 27, 2025
Prognostic role of exercise intensity in familial Filamin C truncating variantsGiulio Savonitto, Alessia Paldino, Martina Setti, et al.
Journal of Medical Genetics|January 12, 2020
<i>FLNC</i> truncations cause arrhythmogenic right ventricular cardiomyopathyFrancesca Brun, Marta Gigli, Sharon L Graw, et al.
Pageof 44

Showing results (181-190 of 431) with videos related to

Sort By:
Pageof 44
European Heart Journal Supplements : Journal of the European Society of Cardiology|February 21, 2025
Critical analysis of the 2023 ESC guidelines on cardiomyopathy managementMaria Perotto, Carola Pio Loco Detto Gava, Maddalena Rossi, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 31, 2018
Early occurrence of drug intolerance as risk factor during follow-up in patients with acute coronary syndrome or coronary revascularizationStefano Albani, Enrico Fabris, Sara Doimo, et al.
Circulation. Genomic and Precision Medicine|April 1, 2026
Twenty-Five-Year Follow-Up of the MDDC1 Family: A <i>LMNA</i> Gene Variant Associated With Dilated Cardiomyopathy With Variable Skeletal Muscle InvolvementTeresa Maria Capovilla, Manuela Iseppi, Salvatore Distaso, et al.
Heart Rhythm|April 15, 2026
Incidence and predictors of major arrhythmic events following acute myocarditis complicated by ventricular arrhythmias: a systematic review and meta-analysisSoundous M'Rabet, Elisé G Kaboré, Moshe Rav-Acha, et al.
The American Journal of Cardiology|May 3, 2011
Predictors for restoration of normal left ventricular function in response to cardiac resynchronization therapy measured at time of implantationLaura Vitali Serdoz, Elisabetta Daleffe, Marco Merlo, et al.
The American Journal of Cardiology|December 20, 2011
How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with "SCD-HeFT criteria?"Massimo Zecchin, Marco Merlo, Alberto Pivetta, et al.
Heart Failure Clinics|November 15, 2021
The Arrhythmic Phenotype in CardiomyopathyMarco Merlo, Giulia Grilli, Chiara Cappelletto, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|April 16, 2024
Management of hypertrophic cardiomyopathyYuhui Zhang, Marianna Adamo, Changhong Zou, et al.
Open Heart|August 27, 2025
Prognostic role of exercise intensity in familial Filamin C truncating variantsGiulio Savonitto, Alessia Paldino, Martina Setti, et al.
Journal of Medical Genetics|January 12, 2020
<i>FLNC</i> truncations cause arrhythmogenic right ventricular cardiomyopathyFrancesca Brun, Marta Gigli, Sharon L Graw, et al.
Pageof 44